| Product Name | MF | CAS | Details |
|---|
| 1-Methyl-3-Propylbenzene | C10H14 | 1074-43-7 | Details |
| H-RPEDQELESLSAIEAELEK-OH | Details |
| Methyl 4,6-dibromonicotinate | C7H5Br2NO2 | 1364663-27-3 | Details |
| Ethyl 3-(furfurylthio)propionate | C10H14O3S | 94278-27-0 | Details |
| 1-Methoxy-3-(trimethylsilyloxy)-1,3-butadiene | C8H16O2Si | 59414-23-2 | Details |
| Influenza A Virus Antigen, Strain A/New Caledonia/20/99 (H1N1) | Details |
| 2-Bromo-5-acetylpyridine | C7H6BrNO | 139042-59-4 | Details |
| Ethyl 2-(1,1-dioxidothietan-3-ylidene)acetate | C7H10O4S | 1394319-79-9 | Details |
| Butane-1,3-diamine dihydrochloride | C4H14Cl2N2 | 106763-37-5 | Details |
| 4-tert-Butyl-6-chloro-2-(propan-2-yl)pyrimidine | C11H17ClN2 | 1153410-79-7 | Details |
| Glycerine | C3H8O3 | 56-81-5 | Details |
| Hepcidin/LEAP-1 (Human) (Bulk) | C113H178N34O31S9 | 342790-21-0 | Details |
| 6-(2,2-Difluoroethoxy)pyridine-2-carboxylic acid | C8H7F2NO3 | 1423754-84-0 | Details |
| 3'-Amino-2',3'-dideoxy-5'-O-DMT-N2-isobutyrylguanosine | C35H38N6O6 | Details |
| 3,5-Dibenzoyloxytoluene | C21H16O4 | 104311-36-6 | Details |
| 2-(N-Morpholino)ethanesulfonic acid monohydrate | C6H15NO5S | 145224-94-8 | Details |
| N-(4-ethoxyphenyl)-3-(4-(2-methylpropyl)phenyl)prop-2-enamide | C21H25NO2 | 329777-63-1 | Details |
| 3-[(tert-Butyldimethylsilyl)oxy]oxolane-3-carbaldehyde | C11H22O3Si | 2168724-86-3 | Details |
| 2-Amino-1-(3,4-dichloro-phenyl)-ethanol | C8H9Cl2NO | 3567-82-6 | Details |
| 2-Bromo-1-phenylbutan-1-one | C10H11BrO | 877-35-0 | Details |
| Recombinant Mouse gAcrp30 (Adipocyte Complement-Related Protein) | Details |
| tert-Butyl N-[3-(3-methylpiperidin-1-yl)-3-oxopropyl]carbamate | C14H26N2O3 | 1016744-33-4 | Details |
| 2-(3-Methylphenyl)-2-(morpholin-4-yl)ethan-1-amine | C13H20N2O | 927966-24-3 | Details |
| 2,3-Dichloro-5,6-dicyanobenzoquinone | C8Cl2N2O2 | 84-58-2 | Details |
| Triiodothyronine-HRP | Details |
| Apigenin - 94% | C15H10O5 | 520-36-5 | Details |
| 2-Methyl-1-(pyridin-4-yl)propan-1-amine | C9H14N2 | 62398-35-0 | Details |
| Diethyl 3-hydroxyglutarate | C9H16O5 | 32328-03-3 | Details |
| Azo-Xyloglucan | Details |
| 3-Ethoxyspiro[3.3]heptan-1-amine | C9H17NO | 1354961-64-0 | Details |
| [4-(4-Methoxyphenyl)phenyl]methanamine hydrochloride | C14H16ClNO | 82487-45-4 | Details |
| 2-[4-(2,2-Difluoroethanesulfinyl)phenyl]acetic acid | C10H10F2O3S | 1339464-70-8 | Details |
| (2-Hydroxyphenyl)boronic acid | C6H7BO3 | 89466-08-0 | Details |
| Linsitinib | C26H23N5O | 867160-71-2 | Details |
| t-Butyl methyl fumarate | C9H14O4 | 55556-66-6 | Details |
| (S)-Benzyl 2-amino-4-methylpentanoate hydrochloride | C13H19NO2.ClH | 2462-35-3 | Details |
| H-VL^AVTDSPAR-OH | Details |
| Hsp70 1A antibody | Details |
| TIPRL antibody | Details |
| 1,2,3,6-Tetra-O-benzyl-4-O-(2,3-di-O-benzyl-4,6-O-benzylidene-a-D-mannopyranosyl)-b-D-glucopyranoside | C62H64O11 | 1040747-78-1 | Details |
| 21,23:24,25-Diepoxy-21,23-dimethoxytirucall-7-en-3-one | C32H50O5 | 1351617-74-7 | Details |
| BCIP dipotassium | C8H4BrClK2NO4P | 102185-49-9 | Details |
| 3-(4-Benzyl-5-sulfanyl-4H-1,2,4-triazol-3-yl)-N,N-diethylbenzene-1-sulfonamide | C19H22N4O2S2 | 554404-39-6 | Details |
| N-[4-(2-Bromoethyl)phenyl]acetamide | C10H12BrNO | 39232-06-9 | Details |
| rac-(1R,3S)-3-Ethoxy-2,2-dimethylcyclobutyl methanesulfonate | 1932776-12-9 | Details |
| AGPAT4 antibody | Details |
| 3-{[(3,4-Dichlorophenyl)methyl]amino}propan-1-ol hydrochloride | C10H14Cl3NO | 1135064-72-0 | Details |
| Solasurine | C39H63NO11 | 27028-76-8 | Details |
| 1-(5-Bromo-1H-pyrrolo[2,3-b]pyridin-3-yl)ethanone | C9H7BrN2O | 866545-96-2 | Details |
| H-GPYV-OH | Details |
| Morin | C15H10O7 | 480-16-0 | Details |
| [(3,5-Dichloropyridin-2-yl)methyl](methyl)amine hydrochloride | C7H9Cl3N2 | 2241131-09-7 | Details |
| (((3,4-dimethoxyphenyl)methyl)amino)(4-(3-chloro-5-(trifluoromethyl)(2-pyridyl))(1,4-diazaperhydroepinyl))methane-1-thione | C21H24ClF3N4O2S | 1022362-61-3 | Details |
| CJ-13610 | C22H23N3O2S | 179420-17-8 | Details |
| Glutathione S-transferase | 50812-37-8 | Details |
| 4-(1-Hydroxyethyl)benzeneboronic acid, pinacol ester | C14H21BO3 | 1173922-30-9 | Details |
| 3-iodo-1H-indazole-5-carbonitrile | C8H4IN3 | 944898-90-2 | Details |
| N,N-Dimethyl-6-(1H-pyrazol-1-yl)pyridine-3-carboxamide | C11H12N4O | 321533-80-6 | Details |
| 1-(2-Bromoethyl)-1H-pyrazole hydrobromide | C5H8Br2N2 | 1955531-53-9 | Details |
| MitTx | Details |
| Methyl 6-phenyl-5-(p-tolyl)picolinate | C20H17NO2 | 1011301-80-6 | Details |
| 1-Fluoro-2-trifluoromethanesulfinylbenzene | C7H4F4OS | 350985-42-1 | Details |
| BRAK antibody | Details |
| N-[(3-Bromophenyl)methyl]oxan-4-amine | C12H16BrNO | 1155634-49-3 | Details |
| Baricitinib trifluoroacetate | C18H18F3N7O4S | 1187594-10-0 | Details |
| Angiotensin I-converting enzyme inhibitor 10 | C13H25N3O4 | 140941-09-9 | Details |
| 2-[(1,1-Dioxo-1,2-benzothiazol-3-yl)sulfanyl]propanoic acid | C10H9NO4S2 | 848179-09-9 | Details |
| ZCCHC3 antibody | Details |
| Methyl 4-{[(tert-butoxy)carbonyl]amino}pyrrolidine-3-carboxylate hydrochloride | C11H21ClN2O4 | 2171902-24-0 | Details |
| ALDH1B1 Blocking Peptide | Details |
| 2-(3-Hydroxypyrrolidin-3-yl)acetonitrile hydrochloride | C6H11ClN2O | 1909313-98-9 | Details |
| tert-Butyl 3-(hydroxyimino)azetidine-1-carboxylate | C8H14N2O3 | 1378674-88-4 | Details |
| SLC13A2 Blocking Peptide | Details |
| Biotin-SARS-CoV-2 Spike RBD 395-430 peptide | Details |
| JNK antibody (Thr183) | Details |
| 1-(3-Methyl-1H-pyrazol-1-yl)propan-2-amine | C7H13N3 | 957261-74-4 | Details |
| 4-Nitrophenyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-a-D-glucopyranoside | C20H24N2O11 | 13089-23-1 | Details |
| 1-phenyl-N-[4-(phenylamino)phenyl]cyclopentane-1-carboxamide | C24H24N2O | 1023513-81-6 | Details |
| 5-(4-Methoxyphenyl)-1,3-thiazole | C10H9NOS | 68535-58-0 | Details |
| Pcna, His tagged human | 872235-73-9 | Details |
| 3-Oxocyclooctane-1-carboxylic acid | C9H14O3 | 27531-69-7 | Details |
| GLU2B antibody | Details |
| N-(4-Amino-2-fluorophenyl)-3-chlorobenzamide | C13H10ClFN2O | 1283396-12-2 | Details |
| 3-(1H-Pyrazol-1-ylmethyl)-1-benzofuran-2-carboxylic acid | C13H10N2O3 | 1152519-08-8 | Details |
| Dusp19 Blocking Peptide | Details |
| 3-Cyclopropyl-1-ethyl-1H-pyrazole-5-carbonitrile | C9H11N3 | 1171385-67-3 | Details |
| 6-Phenyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2-carbaldehyde | C14H13NOS | 1272811-40-1 | Details |
| N,1-Dibutyl-2-sulfanyl-1H-1,3-benzodiazole-5-sulfonamide | C15H23N3O2S2 | 379253-58-4 | Details |
| 2,5-Difluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | C11H14BF2NO2 | 1256358-86-7 | Details |
| 2-(Furan-2-yl)-1,3-thiazole-5-carboxylic acid | C8H5NO3S | 1094230-08-6 | Details |
| MED8 Blocking Peptide | Details |
| 1-[(4-Chlorophenyl)methyl]piperidin-4-amine | C12H17ClN2 | 78471-44-0 | Details |
| Methyl 3-(cyclopropylamino)oxetane-3-carboxylate | C8H13NO3 | 1522173-21-2 | Details |
| 6,6'-Di-O-tert-butyldimethylsilyl-lactal | C24H48O9Si2 | 142800-37-1 | Details |
| 4-[(2-Aminopyrimidin-4-yl)amino]benzene-1-sulfonamide hydrochloride | C10H12ClN5O2S | 22199-93-5 | Details |
| 2-Hydroxyquinoline-8-carboxylic acid | C10H7NO3 | 83734-48-9 | Details |
| HIV2 gp36 ROD protein (HRP) | Details |
| EBV BZLF1 (40-48) (HLA-E) | Details |
| Validamycin (technical) | C20H35NO13 | 50642-14-3 | Details |
| H-SLMEQIPHL^-OH | Details |
| Product Total： Product Page： | ||||
| 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 | ||||